A team of researchers led by Dr. Paddy Chan Kwok-leung of the Mechanical Engineering Department at the University of Hon...
China's leading one-stop healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited has announced ...
Shanghai ChemPartner, a leading life science organization providing high-quality and cost-effective drug discovery and d...
Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines ...
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance ...
Haisco Pharmaceutical Group Co Ltd, a China-based company focused on the research and development and marketing of thera...
Synergy Pharmaceuticals recently announced that the company has entered into a license agreement with Luoxin Pharm...
JHL Biotech has received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of ...
EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into ...
Australian and Chinese scientists have developed a method using coded nanoparticles to detect and help diagnose disease....
Ascletis Pharma Inc announced Ravidasvir is recommended by the World Health Organization (WHO) Guidelin...
On August 8, 2018, Beijing time I-Mab Biopharma ("I-Mab"), a Shanghai-based biotech company focused on innovative biolog...
Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbocic...
Glenmark Pharmaceuticals S.A. and Harbour BioMed have entered into an exclusive license agreement for the Greater C...
Cure Genetics Co., Ltd., a biotechnology company dedicated to the development of life-saving transformative medicines an...
IMPACT Therapeutics a China-based clinical-stage biopharmaceutical company dedicated to the discovery and development of...
Laekna Inc., a biotechnology company headquartered in Shanghai has announced the signing of an agreement with Novartis P...
Legend Capital, the venture and growth capital arm of China’s Legend Holdings Ltd, has co-led an RMB2 billion ($29...
